The South Proxa-Rescue AndroCoV Trial Against COVID-19

NCT05126628 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

133

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Proxalutamide
DRUG: Placebo

Sponsor

Corpometria Institute

Collaborators

[object Object]
[object Object]
[object Object]